0001209191-18-014826.txt : 20180301
0001209191-18-014826.hdr.sgml : 20180301
20180301121441
ACCESSION NUMBER: 0001209191-18-014826
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180228
FILED AS OF DATE: 20180301
DATE AS OF CHANGE: 20180301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KING RICHARD
CENTRAL INDEX KEY: 0001013702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36399
FILM NUMBER: 18655570
MAIL ADDRESS:
STREET 1: C/O KOS PHARMACEUTICALS INC
STREET 2: 1001 BRICKELL AVE 25TH FL
CITY: MIAMI
STATE: FL
ZIP: 33131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001328143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421560076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-3554
MAIL ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050524
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-28
0
0001328143
Adamas Pharmaceuticals Inc
ADMS
0001013702
KING RICHARD
C/O ADAMAS PHARMACEUTICALS, INC.
1900 POWELL ST., SUITE 750
EMERYVILLE
CA
94608
0
1
0
0
Chief Operating Officer
Common Stock
2018-02-28
4
A
0
10000
25.07
A
39661
D
The shares were purchased at prices ranging from $25.05 to $25.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Includes 1,536 shares purchased on 11/30/17 through the issuer's employee stock purchase plan.
/s/ Jennifer Rhodes, Attorney-in-fact
2018-03-01